| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |